ESR1 and breast cancer: Some groups have combined both approaches, such as, Rhothé et al., who analyzed a global miRNA expression profile from 89 ER positive BC patients and detected that miR-210 is clinically relevant due to its high expression being correlated with relapse-free survival (p = 0.004).